Mehrdad Hadadian is a Ph.D. student at the Adelaide Medical School, working within the ENT Surgery Group. His primary research interests lie in advanced drug delivery systems and nanomaterials, operating at the intersection of organic chemistry and pharmaceutical science.
His research focuses on enhancing the bioavailability and targeted delivery of therapeutics through the design and development of advanced nanocarriers, with the goal of improving clinical efficacy and enabling innovative pharmaceutical formulations.
Mehrdad’s expertise includes physicochemical characterization, computational modeling, and the synthesis and fabrication of functional materials such as cyclodextrin-based carriers and nanosponges. Currently, his work involves the preparation of biopolymer hydrogels and the development of advanced drug formulations for targeted biomedical delivery and the prevention of chronic diseases.